Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Better Buy: Biogen vs. Amgen

TheMotleyFool

0 0

Better Buy: Biogen vs. AmgenPhoto, wide shot, wide-angle lens, Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png

Choosing between biotech giants Biogen (NASDAQ: BIIB) and Amgen (NASDAQ: AMGN) is not an easy task. Both companies have attractive pipelines and solid suites of products on the market. Though Amgen's revenue declined in 2019 while Biogen's rose, Amgen offered a better revenue outlook for 2020.

Both stocks make a great addition to a biotech portfolio, but before deciding which one is the best buying opportunity right now amid all the market volatility, let's take a closer look at their sales, products, and prospects.

Image source: Getty Images.

Source Fool.com

Like: 0

AMGN

Share